24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ENZYME DYNAMICS |
29.77% |
|
ANTIBODY DYNAMICS |
27.48% |
|
IL 2 RECEPTOR DYNAMICS |
27.48% |
|
IL 2 DYNAMICS SIMULATIONS |
9.92% |
|
IL 2 FORCE FIELD BENCHMARKING |
5.34% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ANTIBODY DYNAMICS |
28.3% |
|
ENZYME DYNAMICS |
24.09% |
|
IL 2 RECEPTOR DYNAMICS |
15.3% |
|
ANTIBODY DYNAMICS SIMULATION |
11.85% |
|
IL 2 DYNAMICS SIMULATIONS |
9.75% |
|
ANTIBODY AFFINITY MATURATION |
9.37% |
|
IL 2 FORCE FIELD BENCHMARKING |
1.34% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
CANCER |
21.19% |
|
ANTIBODY DYNAMICS |
16.39% |
|
ANTIBODY DYNAMICS SIMULATION |
12.5% |
|
IL 2 FORCE FIELD BENCHMARKING |
10.21% |
|
ANTIBODY AFFINITY MATURATION |
10.14% |
|
ALZHEIMERS |
7.93% |
|
IL 2 RECEPTOR DYNAMICS |
7.05% |
|
IL 2 DYNAMICS SIMULATIONS |
4.52% |
|
ENZYME DYNAMICS |
4.4% |
|
STP6 SUGAR TRANSPORT |
1.98% |
|
ANTIBODY MATURATION SIMULATION |
1.22% |
|
IL 2 MOLECULAR DYNAMICS |
.93% |
|
ATSTP10 SUCROSE TRANSPORT |
.72% |
|
IL2 RECEPTOR DYNAMICS |
.5% |
|
SUCROSE TRANSPORT PLANTS |
.32% |